609 related articles for article (PubMed ID: 30937839)
21. Probiotics alleviate inflammatory bowel disease in mice by regulating intestinal microorganisms-bile acid-NLRP3 inflammasome pathway.
Liu Z; Wang H
Acta Biochim Pol; 2021 Oct; 68(4):687-693. PubMed ID: 34648252
[TBL] [Abstract][Full Text] [Related]
22. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation.
Wang L; Wang Y; Wang Z; Qi Y; Zong B; Liu M; Li X; Zhang X; Liu C; Cao R; Ma Y
Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G909-G920. PubMed ID: 30188752
[TBL] [Abstract][Full Text] [Related]
23. NLRP3-Dependent and -Independent Processing of Interleukin (IL)-1β in Active Ulcerative Colitis.
Ranson N; Veldhuis M; Mitchell B; Fanning S; Cook AL; Kunde D; Eri R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583612
[TBL] [Abstract][Full Text] [Related]
24. NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases.
Zhang Y; Yang W; Li W; Zhao Y
Front Immunol; 2021; 12():732933. PubMed ID: 34707607
[TBL] [Abstract][Full Text] [Related]
25. Huaier aqueous extract protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NLRP3 inflammasome activation.
Wang L; Yu Z; Wei C; Zhang L; Song H; Chen B; Yang Q
Oncotarget; 2017 May; 8(20):32937-32945. PubMed ID: 28380426
[TBL] [Abstract][Full Text] [Related]
26. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production.
Gong Z; Zhao S; Zhou J; Yan J; Wang L; Du X; Li H; Chen Y; Cai W; Wu J
Mol Immunol; 2018 Dec; 104():11-19. PubMed ID: 30396035
[TBL] [Abstract][Full Text] [Related]
27. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
[TBL] [Abstract][Full Text] [Related]
28. Xi Lei San Attenuates Dextran Sulfate Sodium-Induced Colitis in Rats and TNF-
Tao Z; Zhou X; Zhang Y; Pu W; Yang Y; Wei F; Zhou Q; Zhang L; Du Z; Wu J
Mediators Inflamm; 2021; 2021():1610251. PubMed ID: 33967625
[TBL] [Abstract][Full Text] [Related]
29. Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases.
Zhong Z; Sanchez-Lopez E; Karin M
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):12-6. PubMed ID: 27586797
[TBL] [Abstract][Full Text] [Related]
30. NLRP3: A promising therapeutic target for autoimmune diseases.
Shen HH; Yang YX; Meng X; Luo XY; Li XM; Shuai ZW; Ye DQ; Pan HF
Autoimmun Rev; 2018 Jul; 17(7):694-702. PubMed ID: 29729449
[TBL] [Abstract][Full Text] [Related]
31. Qingre Jianpi decoction attenuates inflammatory responses by suppressing NOD-like receptor family pyrin domain-containing 3 inflammasome activation in dextran sulfate sodium-induced colitis mice.
Zhang J; Kang X; Sun M; Zhang S
J Tradit Chin Med; 2021 Feb; 41(1):68-78. PubMed ID: 33522199
[TBL] [Abstract][Full Text] [Related]
32. NLRP3 Inflammasome in Atherosclerosis: Putting Out the Fire of Inflammation.
Shao BZ; Xu HY; Zhao YC; Zheng XR; Wang F; Zhao GR
Inflammation; 2023 Feb; 46(1):35-46. PubMed ID: 35953687
[TBL] [Abstract][Full Text] [Related]
33. The NLRP3 Inflammasome as a Pharmacological Target.
Marchetti C
J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
[TBL] [Abstract][Full Text] [Related]
34. [Role of NLRP1 and NLRP3 inflammasome signaling pathways in the immune mechanism of inflammatory bowel disease in children].
Wang H; Ma YC
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Aug; 22(8):854-859. PubMed ID: 32800032
[TBL] [Abstract][Full Text] [Related]
35. Palmatine attenuated dextran sulfate sodium (DSS)-induced colitis via promoting mitophagy-mediated NLRP3 inflammasome inactivation.
Mai CT; Wu MM; Wang CL; Su ZR; Cheng YY; Zhang XJ
Mol Immunol; 2019 Jan; 105():76-85. PubMed ID: 30496979
[TBL] [Abstract][Full Text] [Related]
36. Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease.
Chen QL; Yin HR; He QY; Wang Y
Biomed Pharmacother; 2021 Jun; 138():111442. PubMed ID: 33667791
[TBL] [Abstract][Full Text] [Related]
37. Emerging role of exosomes in ulcerative colitis: Targeting NOD-like receptor family pyrin domain containing 3 inflammasome.
Li X; Ji LJ; Feng KD; Huang H; Liang MR; Cheng SJ; Meng XD
World J Gastroenterol; 2024 Feb; 30(6):527-541. PubMed ID: 38463022
[TBL] [Abstract][Full Text] [Related]
38. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Lee S; Suh GY; Ryter SW; Choi AM
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
[TBL] [Abstract][Full Text] [Related]
39. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.
Qiu YY; Tang LQ
Pharmacol Res; 2016 Dec; 114():251-264. PubMed ID: 27826011
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the therapeutic effects of mycophenolate mofetil targeting Nrf-2 and NLRP3 inflammasome in acetic acid induced ulcerative colitis in rats.
Serrya MS; El-Sheakh AR; Makled MN
Life Sci; 2021 Apr; 271():119154. PubMed ID: 33539910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
